Clinical ScienceImprovement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity
Introduction
Abdominal obesity, characterized by excess visceral adipose tissue (VAT) and ectopic fat deposition, has been associated with a cluster of atherogenic and diabetogenic abnormalities [1]. However, pharmacological approaches to target VAT accumulation are virtually nonexistent since the withdrawal of some of the few available antiobesity drugs [2], [3]. Several lifestyle intervention studies using exercise as the treatment modality have shown its ability to mobilize VAT and improve the cardiometabolic risk (CMR) profile, even in the absence of weight loss [4], [5]. In the well-known Diabetes Prevention Study (DPS) [6] and Diabetes Prevention Program (DPP) [7], a 58% reduction in the incidence of type 2 diabetes mellitus (T2D) was reported in patients with glucose intolerance following a lifestyle modification program focusing on healthy eating and increased physical activity. However, only few studies have addressed the question of whether it has beneficial effects on indices of plasma glucose/insulin homeostasis specifically among men selected on the basis of their excess visceral adiposity who were further classified on the basis of their glucose tolerance [7], [8], [9]. For instance, a recent study has shown that the reduction in T2D's incidence related to physical activity was heterogeneous depending upon the glucose tolerance status of participants assessed at baseline [9].
The present study was designed as a body composition/adipose tissue distribution lifestyle intervention to examine how a healthy eating, physical activity/exercise program could improve the CMR profile of a group of viscerally obese men with the atherogenic dyslipidemia of insulin resistance. Participants did not have T2D; and the study included subjects with both normal and impaired glucose tolerance, aiming at specifically targeting excess visceral adiposity rather than metabolic disturbances. Key inclusion criteria were the presence of abdominal obesity and the high triglyceride/low high-density lipoprotein (HDL) cholesterol atherogenic dyslipidemia that is a lipid phenotype associated with excess VAT [10]. The primary end point of the intervention was visceral adiposity measured by computed tomography. We put forward the hypothesis that a 1-year lifestyle modification program integrating healthy eating habits combined with an increase in physical activity and endurance exercise could lead to improvements in insulin sensitivity, irrespective of patients' glucose tolerance status. We also examined whether changes in body fat distribution vs changes in cardiorespiratory fitness (CRF) would contribute to the improvements in indices of plasma glucose/insulin homeostasis.
Section snippets
Study design
One hundred forty-four men, between the ages of 30 and 65 years and presenting with abdominal obesity (waist circumference ≥90 cm), triglyceride levels of at least 1.69 mmol/L, and/or HDL cholesterol less than 1.03 mmol/L, were recruited by solicitation in the media to participate to a 3-year lifestyle modification program (the “SYNERGIE” study, to emphasize the synergism between healthy eating and increased physical activity/exercise). Men with T2D, with body mass index (BMI) values less than
Results
From the 144 men who were initially involved in the study, 35 men dropped out during the first year, whereas 5 men did not have complete OGTT data. The men who completed the 1-year intervention/evaluation presented slightly higher BMI (31.2 ± 3.1 vs 30.1 ± 2.8 for the men who completed the 1-year intervention/evaluation vs the men who did not, respectively; P = .04), higher fasting insulin (173 ± 74 vs 141 ± 78, respectively; P = .03), higher HOMA-IR (6.47 ± 2.95 vs 5.10 ± 2.77, respectively; P
Discussion
The present study is not a randomized trial to quantify the effects of a lifestyle modification program on the CMR profile. Indeed, whether a lifestyle modification program can improve the CMR profile has already been very well documented [6], [7], [29], [30], [31], [32]. Instead, the present study was designed to test whether a 1-year healthy eating–physical activity/exercise program would change the insulin sensitivity of viscerally obese dyslipidemic men, regardless of their glucose
Conclusion
The present 1-year healthy eating–physical activity/exercise intervention program substantially improved indices of plasma glucose/insulin homeostasis in viscerally obese dyslipidemic men, regardless of their glucose tolerance status at baseline. As a consequence, the majority of participants improved or stabilized their glucose tolerance status over the 1-year intervention. However, lack of CRF improvement and limited losses in VAT and SAT defined a subgroup of subjects who failed to improve
Funding source
This study was supported by the Canadian Institutes of Health Research.
Conflict of Interest
No conflict of interest.
Acknowledgment
Dr Borel is a postdoctoral fellow supported by a fellowship from Agiràdom (Meylan, France) and the Rhône-Alpes region (France). Dr Nazare is a postdoctoral fellow supported by a fellowship from “Fondation Bullukian” and “Institut Appert.” Jessica Smith is a post-doctoral fellow supported by a fellowship from the International Chair on Cardiometabolic Risk. Dr Paul Poirier is a senior clinical researcher of the Fonds de recherche en santé du Québec.
References (49)
- et al.
[On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins.]
Clin Chim Acta
(1960) - et al.
Effects of a 6-month lifestyle modification intervention on the cardiometabolic risk factors and health-related qualities of life in women with metabolic syndrome
Metabolism
(2010) - et al.
Reducing visceral adipose tissue mass is essential for improving endothelial function in type 2 diabetes prone individuals
Atherosclerosis
(2010) - et al.
Inverse associations between muscle mass, strength, and the metabolic syndrome
Metabolism
(2009) - et al.
Abdominal obesity and metabolic syndrome
Nature
(2006) - et al.
CB1 antagonists for obesity—what lessons have we learned from rimonabant?
Nat Rev Endocrinol
(2009) - et al.
Impact of weight-loss medications on the cardiovascular system: focus on current and future anti-obesity drugs
Am J Cardiovasc Drugs
(2007) - et al.
Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial
Ann Intern Med
(2000) - et al.
Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study
Med Sci Sports Exerc
(2003) - et al.
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
N Engl J Med
(2001)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
N Engl J Med
Lifestyle intervention in individuals with normal versus impaired glucose tolerance
Eur J Clin Invest
Differential relationship between physical activity and progression to diabetes by glucose tolerance status: the Inter99 Study
Diabetologia
Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?
Circulation
Techniques for the measurement of visceral fat: a practical guide
Int J Obes Relat Metab Disord
Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements
Br J Nutr
Effect of rimonabant on the high-triglyceride/low–HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial
Arterioscler Thromb Vasc Biol
Is the relationship between adipose tissue and waist girth altered by weight loss in obese men?
Obes Res
ACSM's guidelines for exercise testing and prescription
[Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method]
Schweiz Med Wochenschr
Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays
J Clin Endocrinol Metab
Radioimmunological determination of human C-peptide in serum
Diabetologia
Impaired fasting glucose and impaired glucose tolerance: implications for care
Diabetes Care
Cited by (32)
Changes in IGFBP-2 levels following a one-year lifestyle modification program are independently related to improvements in plasma apo B and LDL apo B levels
2019, AtherosclerosisCitation Excerpt :Again, similar data were observed when relative changes in IGFBP-2 were used instead of absolute changes in IGFBP-2 levels (data not shown). In addition, as reported [32], changes in fasting insulin, HOMA-IR and AUC glucose were not significantly associated with changes in plasma, LDL or VLDL apo B levels (data not shown). Taken together, these findings suggest that the increase in IGFBP-2 levels following the one-year intervention program overwhelmed the improvements in insulin sensitivity and potentially visceral adiposity as the main modulators of LDL apo B concentrations.
Association of decrease in carbohydrate intake with reduction in abdominal fat during 3-month moderate low-carbohydrate diet among non-obese Japanese patients with type 2 diabetes
2015, Metabolism: Clinical and ExperimentalCitation Excerpt :Abdominal fat accumulation, both of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT), is known to be strongly linked to the development of metabolic diseases [1–6] even among non-obese individuals [7,8]. Various diet and/or exercise interventions, including low carbohydrate diets (LCDs) [9,10], have reduced an excess of abdominal fat [11–14] and have been studied in various branches of medicine. The effectiveness has been attributed to unique mechanisms, including control of appetite, hormones, nervous system, weight and blood lipids and glucose [15–18].
Adolescent and young adult female determinants of visceral adipose tissue at ages 26-28 years
2015, Journal of PediatricsCitation Excerpt :When waist and BMI were excluded from the roster of independent variables for VAT, insulin in adolescence (partial R2 11.6%) and young adulthood (partial R2 41.6%) were predominant independent variables, and HDL-C was an inverse independent variable, consistent with the findings of Miazgowski et al.43 Insulin and HOMA-IR were related closely to waist circumference and to BMI, and their appearance as predominant independent variables for VAT when waist and BMI were excluded from the roster of independent variables was expected. Reduction of VAT in a 1-year lifestyle intervention was associated with improved insulin sensitivity.44,45 When BMI and waist circumference were included as potential independent variables for VAT, waist circumference was the most important independent variable, accounting for up to 61.7% of the variance of VAT.
Differences in the redox status of human visceral and subcutaneous adipose tissues - Relationships to obesity and metabolic risk
2014, Metabolism: Clinical and ExperimentalCitation Excerpt :The observation that visceral adiposity is particularly deleterious to health [7] has prompted a detailed examination of different fat depots. A wealth of clinical, epidemiological and physiological data has shown many intrinsic biological differences in the fat tissues from subcutaneous and visceral depots [8–12]. The most obvious distinction between these two fat depots is that visceral adipocytes are characterised by higher metabolic activity, basal glucose uptake, and responsiveness to lipolytic stimulation and poorer antilipolytic regulation by insulin [13–15].
Visceral adiposity and the risk of metabolic syndrome across body mass index: The MESA study
2014, JACC: Cardiovascular ImagingCitation Excerpt :In animal models of obesity, dysfunctional visceral adipocytes represent a locus of inflammation and insulin resistance (15,16). Indeed, in humans, an improvement in insulin sensitivity is associated with changes in VF (17), and inflammation within visceral adipose tissue is associated with systemic insulin resistance, inflammation, and endothelial dysfunction (18). VF has been associated with cardiovascular events (4), left ventricular remodeling (19), and dysglycemia (2,3,20,21) in multiple large, community-based cohorts (e.g., the Dallas, Jackson, and Framingham Heart Studies).
Authors contribution: Anne-Laure Borel: data analysis, data interpretation and manuscript writing. Julie-Anne Nazare: data interpretation and critical revision. Jessica Smith: data interpretation and critical revision. Natalie Alméras: design conception, conduct of the study, and critical revision. Angelo Tremblay: design conception and critical revision. Jean Bergeron: design conception and critical revision. Paul Poirier: design conception and critical revision. Jean-Pierre Després: design conception, conduct of the study, data interpretation, critical revision.